Immunomodulatory Effect of Novel Electrospun Nanofibers Loaded with Doxycycline as an Adjuvant Treatment in Periodontitis.
biomarkers
biomaterial
doxycycline
electrospinning
immunomodulator
nano-hydroxyapatite
nanofibers
periodontitis
polylactic acid
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
20 Feb 2023
20 Feb 2023
Historique:
received:
22
12
2022
revised:
04
02
2023
accepted:
07
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
The immunomodulatory effect of a novel biomaterial obtained through electrospinning, based on polylactic acid (PLA) and nano-hydroxyapatite (nano-HAP), loaded with doxycycline (doxy) was evaluated in an animal model. The treatment capabilities as a local non-surgical treatment of periodontitis was investigated on the lower incisors of Wistar rats, after the induction of localized periodontitis using the ligature technique. Following the induction of the disease, the non-surgical treatment of scaling and root planing was applied, in conjunction with the application of the new material. The results of the treatment were evaluated clinically, using the tooth mobility and gingival index scores, as well as histologically. The salivary concentrations of matrix metalloproteinase 8 (MMP-8) and plasmatic concentrations of interleukin 1 (IL-1), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) were also monitored. Two weeks after the ligature application, the periodontal disease was successfully induced in rats. The application of the novel biomaterial obtained through electrospinning was proven to be more effective in improving the clinical parameters, while decreasing the salivary MMP-8 and plasmatic IL-1 and TNF-α concentrations, compared to the simple scaling and root planing. Thus, the novel electrospun biomaterial could be a strong candidate as an adjuvant to the non-surgical periodontal therapy.
Identifiants
pubmed: 36840029
pii: pharmaceutics15020707
doi: 10.3390/pharmaceutics15020707
pmc: PMC9966556
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Research Council
ID : 348PED/03.08.2020
Organisme : University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca
ID : 24905/08.11.2021
Références
Biology (Basel). 2022 Apr 21;11(5):
pubmed: 35625362
Saudi J Biol Sci. 2020 Jun;27(6):1679-1684
pubmed: 32489311
Arch Oral Biol. 2006 Sep;51(9):794-803
pubmed: 16712777
J Periodontol. 2004 Oct;75(10):1387-96
pubmed: 15562917
Periodontol 2000. 2016 Jun;71(1):82-112
pubmed: 27045432
J Periodontol. 2003 Mar;74(3):391-401
pubmed: 12710761
Materials (Basel). 2022 Sep 07;15(18):
pubmed: 36143537
Matrix Biol. 2015 May-Jul;44-46:224-31
pubmed: 25599938
Periodontol 2000. 2017 Oct;75(1):152-188
pubmed: 28758300
Int J Mol Sci. 2022 Feb 04;23(3):
pubmed: 35163727
Biosensors (Basel). 2019 Feb 14;9(1):
pubmed: 30769890
J Appl Microbiol. 2019 Dec;127(6):1612-1626
pubmed: 31021482
Molecules. 2022 Mar 28;27(7):
pubmed: 35408602
J Clin Periodontol. 2020 Jul;47 Suppl 22:4-60
pubmed: 32383274
Expert Opin Drug Deliv. 2017 Nov;14(11):1241-1251
pubmed: 28485988
Mediators Inflamm. 2021 Oct 18;2021:5834608
pubmed: 34707462
J Biomed Biotechnol. 2011;2011:754857
pubmed: 21331345
J Periodontol. 2018 Jun;89 Suppl 1:S173-S182
pubmed: 29926951
J Periodontol. 2022 Jul;93(7):1072-1082
pubmed: 34773704
J Clin Med. 2021 Apr 03;10(7):
pubmed: 33916672
Br J Cancer. 2018 Jul;119(2):213-219
pubmed: 29808017
Oral Dis. 2012 Apr;18(3):236-43
pubmed: 22050374
Cureus. 2022 Jan 6;14(1):e20985
pubmed: 35154961
Nat Rev Immunol. 2021 Jul;21(7):426-440
pubmed: 33510490
J Periodontal Res. 2017 Aug;52(4):651-665
pubmed: 28177120
J Oral Maxillofac Res. 2016 Jun 30;7(2):e2
pubmed: 27489606
J Mater Chem B. 2020 Mar 4;8(9):1781-1800
pubmed: 32065184
Dis Mon. 2019 Jun;65(6):185-192
pubmed: 30384973
Iran J Pharm Res. 2014 Fall;13(4):1319-25
pubmed: 25587321
Materials (Basel). 2022 Mar 12;15(6):
pubmed: 35329557